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Abstract
Local cerebral hypoperfusion causes ischemic stroke while driving multiple cell-specific responses including
inflammation, glutamate-induced neurotoxicity mediated via NMDAR, edema formation and angiogenesis. Despite
the relevance of these pathophysiological mechanisms for disease progression and outcome, molecular
determinants controlling the onset of these processes are only partially understood. In this context, our study
intended to investigate the functional role of EphB2, a receptor tyrosine kinase that is crucial for synapse function
and binds to membrane-associated ephrin-B ligands.
Cerebral ischemia was induced in Ephb2−/− mice by transient middle cerebral artery occlusion followed by different
times (6, 12, 24 and 48 h) of reperfusion. Histological, neurofunctional and transcriptome analyses indicated an
increase in EphB2 phosphorylation under these conditions and attenuated progression of stroke in Ephb2−/− mice.
Moreover, while infiltration of microglia/macrophages and astrocytes into the peri-infarct region was not altered,
expression of the pro-inflammatory mediators MCP-1 and IL-6 was decreased in these mice. In vitro analyses
indicated that binding of EphB2 to astrocytic ephrin-B ligands stimulates NF-κB-mediated cytokine expression via
the MAPK pathway. Further magnetic resonance imaging of the Ephb2−/− ischemic brain revealed a lower level of
cytotoxic edema formation within 6 h upon onset of reperfusion. On the mechanistic level, absence of neuronal
EphB2 decreased the mitochondrial Ca2+ load upon specific activation of NMDAR but not during synaptic activity.
Furthermore, neuron-specific loss of ephrin-B2 reduced the extent of cerebral tissue damage in the acute phase of
ischemic stroke.
Collectively, EphB2 may promote the immediate response to an ischemia-reperfusion event in the central nervous
system by (i) pro-inflammatory activation of astrocytes via ephrin-B-dependent signaling and (ii) amplification of
NMDA-evoked neuronal excitotoxicity.
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Introduction
Cerebral ischemia is one of the leading causes of death
and disability in the Western world while effective thera-
peutic options such as thrombectomy and thrombolysis
are limited to a small number of patients only. There-
fore, unraveling pathophysiological mechanisms under-
lying ischemic stroke is needed to develop novel and
adjuvant therapies. Ischemic stroke due to the occlusion
of a main cerebral artery leads to a critical shortage of
oxygen, glucose and further nutrients in the affected
brain area. The latter initiates a complex cascade of det-
rimental events evolving within different temporal and
spatial frames. This ischemic cascade encompasses initial
bioenergetic failure and ionic imbalance, followed by
excitotoxicity, oxidative stress, dysfunction of the
blood-brain barrier (BBB), and inflammatory responses,
which altogether lead to the progressive death of neu-
rons, glial and endothelial cells [10].
The bioenergetic failure, rapidly occurring due to the
lack of oxygen and glucose, results in breakdown of the
normal resting potential of neurons, depolarization, and
massive glutamate release. Subsequent excessive stimula-
tion of glutamatergic receptors, most notably extrasy-
naptic N-methyl-D-aspartate receptors (NMDARs),
causes calcium overload and mitochondrial dysfunction,
which trigger a range of downstream neurotoxic cas-
cades that impair neuronal function or lead to cell death
(glutamate excitotoxicity) [18, 47]. Unchecked influx of
Na+, K+, and Ca2+ as a result of ischemia-related energy
depletion and glutamate-mediated NMDAR overactiva-
tion, in turn, drives Cl− influx via chloride channels, and
the resultant increase in intracellular osmolarity drives
inflow of water leading to osmotic expansion of the cell
(cytotoxic edema) [30]. Cytotoxic edema represents a
premorbid cellular process that almost inevitably leads
to oncotic or necrotic cell death of mostly astrocytes
and neurons [30].
Cytotoxic edema also supplies the driving force for the
delayed-onset vasogenic edema that is characterized by
extravasation and accumulation of fluid in the cerebral
parenchyma due to structural BBB disruption [30, 37,
48]. The BBB is a selective barrier formed by endothelial
cells that line cerebral microvessels. Tight junctions
(TJs) interconnecting adjacent endothelial cells restrict
the movement of molecules and cells across the intact
BBB. At the molecular level, TJs consist of specialized
transmembrane proteins such as occludin and claudin-5
that are anchored to the actin cytoskeleton via the scaf-
folding protein Zonula occludens (ZO)-1 [24, 32, 46].
During ischemia-reperfusion (I/R) injury, disruption of
regular localization along the cellular borders, increased
proteolytic degradation, or reduced expression of TJ pro-
teins occurs causing loss of junctional integrity, in-
creased paracellular BBB permeability, and vasogenic
edema formation, which is ultimately responsible for
brain swelling in the course of ischemic stroke [24, 46].
As a consequence of neuronal cell death, resident im-
munocompetent cells of the central nervous system
(CNS) such as microglia and astrocytes become rapidly
activated. Early pro-inflammatory activation of glial and
endothelial cells is accompanied by the release of cyto-
kines, chemokines and reactive oxygen species (ROS)
that contribute to the delayed recruitment and transmi-
gration of peripheral immune cells such as neutrophils
and monocytes across the disrupted BBB causing sec-
ondary brain damage [22].
Taken together, the complex ischemic cascade involves
specific spatiotemporal interactions of all parenchymal
brain cells. Important determinants orchestrating
cellular interactions in this context are the
erythropoietin-producing human hepatocellular (Eph) re-
ceptors and their corresponding ligands (ephrins). The
Eph receptors comprise a large family of receptor tyrosine
kinases that not only have important roles in the
establishment of neuronal and vascular networks during
embryonic development, but also coordinate the homeo-
stasis of the adult CNS and many other adult organs [23,
40, 57]. Their ligands are either attached to the cell sur-
face through a glycosylphosphatidylinositol (GPI) linkage
and preferentially bind EphA receptors (ephrin-A) or are
transmembrane proteins that preferentially bind EphB
receptors (ephrin-B). Interactions are promiscuous within
each class, and some Eph receptors can also bind to
ephrins of the other class. A distinctive feature of
Eph-ephrin complexes is their ability to generate bidirec-
tional signals that affect both the receptor-expressing
(“forward” signaling) and ephrin-expressing cells
(“reverse” signaling) [23, 40, 57]. There are several
lines of evidence suggesting an important role of the
EphB receptor/ephrin-B ligand system in stroke path-
ology. Firstly, in glutamatergic neurons, EphB2 receptors
were shown to associate with NMDAR at synaptic sites,
and their activation by ephrin-B ligands modulates
NMDAR-driven Ca2+ influx [50]. Secondly, bidirectional
signaling between ephrin-B2 on reactive astrocytes and
EphB2 on meningeal fibroblasts is an early important
event during development of the glial scar in the adult
CNS in response to injury [6]. Thirdly, bidirectional sig-
naling between monocytic EphB2 and endothelial cell
ephrin-B1 and -B2 promotes adhesion, pro-inflammatory
activation, and transmigration of monocytes, while it
lowers the integrity of interendothelial cell junctions and
provokes a pro-inflammatory phenotype in endothelial
cells [5, 26, 31, 41].
In the light of those findings, our present study
aimed to investigate the impact of EphB2 on the out-
come of ischemic stroke and the responses of brain
parenchymal cells.
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Materials and methods
Mice
All mouse lines were established on a C57Bl/6 back-
ground. We used female and male littermate mice that
were age-matched between experimental groups. Mice
were between 6 and 10 weeks of age. All animal experi-
ments were approved by the local animal welfare com-
mittee (Regierungspräsidium Karlsruhe, Germany,
permission number: 35–9185.81/G-112/13), conformed
to the Guide for the Care and Use of Laboratory Ani-
mals published by the US National Institutes of Health,
and were performed in accordance with the recently
published Animal Research: Reporting In Vivo Experi-
ments (ARRIVE) guidelines (https://www.nc3rs.org.uk/
arrive). All mice were housed at constant room
temperature (22 ± 2 °C) and relative humidity (50–55%)
on a controlled 12:12 h light-dark cycle, and were pro-
vided with standard laboratory chow (LASQCdiet
Rod16; LASvendi, Soest, Germany) and water ad libitum.
Mice homozygous for a null allele of Ephb2 (Ephb2tm1-
Paw; Ephb2−/−) [21] and corresponding wild-type (WT)
littermates were obtained by mating Ephb2 haploinsuffi-
cient (Ephb2+/−) mice. Depletion of EphB2 protein was
confirmed by capillary electrophoresis (Additional file 1:
Figure S1a). Neural cell-specific ephrin-B2 deficient mice
(nEfnb2Δ/Δ) were generated by crossing animals harbor-
ing two floxed alleles (exon 2 flanked by loxP sites) of
the Efnb2 gene (B6.E14-TgH(efnb2flx/flx)RK; Efnb2fl/fl)
[15] with transgenic mice expressing Cre recombinase
under control of the promoter and the nervous
system-specific enhancer present in the second intron of
the rat nestin gene (B6.Cg-Tg(Nes-cre)1Kln) [52].
Cre-mediated excision of floxed exon 2 in the Efnb2
gene was successfully verified on the mRNA level using
real-time RT-PCR (Additional file 1: Figure S1b). Mice
were genotyped using primers (Eurofins Genomics,
Ebersberg, Germany) described in Additional file 2:
Table S1. All mice were randomly allocated to experi-
mental groups. Operators and investigators were blinded
for mouse genotype in all experiments and analyses.
Evaluation of all read-out parameters was done inde-
pendently and in a blinded fashion.
Experimental stroke model
Mice were used at the age of 7–9 weeks. Female and
male mice were anesthetized by a mixture of 2% isoflur-
ane in, 70% N2O and remainder O2, and were main-
tained by reducing the isoflurane concentration to 1.0–
1.5%. To induce focal cerebral ischemia, a 7–0 silicon
rubber-coated nylon monofilament (Doccol Corporation,
Redlands, USA) was introduced in the left internal ca-
rotid artery and pushed toward the left middle cerebral
artery (MCA) as previously described [27]. In subgroups
of mice laser-Doppler flowmetry (LDF) was used to
confirm successful MCA occlusion (MCAO) as reported
previously [27]. The intraluminal suture was left for 60
min. Subsequently, animals were re-anesthetized and the
occluding monofilament was withdrawn to allow reper-
fusion for 6–72 h. For sham surgery, the mice underwent
the same procedure without vessel occlusion. The ani-
mals were maintained at 37 °C during and after surgery
until they were fully recovered from anesthesia. Then,
mice were returned to their solitary cages in a heated
(30 °C) environment with free access to food and water
for 12 h. During the remaining time animals were kept
under normal conditions as described above. Additional
file 2: Table S2 lists the criteria resulting in exclusion
from end-point analysis.
Behavioral assessment
Motor coordination and balance were assessed by using
the Rotarod performance test. Mice were placed indi-
vidually on the revolving drum. Once they were bal-
anced, the drum was accelerated from 4 to 40 rpm over
the course of 300 s, and the time at which the animal
dropped off the drum was determined (maximum test-
ing time 300 s). Mice were trained for three consecutive
days (three runs each) and were tested directly before
MCAO and 24 h after onset of reperfusion. At indicated
time points, neurological function was additionally eval-
uated using the modified Bederson neurological deficit
score, according to the following scoring system: 0, no
observable deficit; 1, forelimb flexion; 2, decreased resist-
ance to lateral push; 3, unidirectional circling; 4, no
movement [4].
Magnetic resonance imaging (MRI)
MRI was performed on a dedicated small animal scanner
with 9.4 Tesla magnetic field strength (BioSpec 94/20
USR, Bruker, Ettlingen, Germany) using a volume coil for
RF transmission and a 4-channel phased-array surface re-
ceiver coil. An isoflurane evaporator connected to a sup-
ply of compressed air was used for anesthesia. Anesthesia
was induced at 2% isoflurane and maintained with 1–
1.5%. Animals were placed in prone and fixed positions on
an animal holder equipped with a headlock and tooth bar
to minimize head motion. Body temperature was main-
tained using a temperature-controlled heating pad. Respir-
ation was monitored externally with an in-house
developed program in LabView (National Instruments
Corporation, Austin, Texas, USA).
The imaging protocol included T2-weighted imaging
(TEeff/TR = 66ms/2650 ms, RARE factor = 8, slice thick-
ness 0.5 mm, 13 slices, matrix 256 × 256, in plane reso-
lution 78 × 78 μm), diffusion-weighted imaging (TEeff/
TR = 20 ms/3400 ms, slice thickness 0.7 mm, one meas-
urement with b = 0 and 30 diffusion sensitized directions
with a b-value of 1500 s/mm2, field-of-view 12 × 15mm,
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matrix 96 × 128, resolution 125 × 117 μm), as well as
quantitative T2 measurements (TE increments of 8 ms
from 8ms to 136ms, TR = 3100ms, slice thickness 0.5
mm, matrix 172 × 172, resolution 116 × 116 μm). The
real signal component from the Multislice Multiple Spin
Echo data were fitted after phase correction and SNR
optimized multiple coils signal combination on a
voxel-by-voxel basis with the monoexponential function
S0*e
–(TE/T2) using a nonlinear least-squares fit procedure
(MATLAB Release 2012b, The MathWorks, Inc., Natick,
Massachusetts, United States). S0 is the signal at TE = 0.
Apparent diffusion coefficient (ADC) values were ob-
tained from diffusion-weighted images by FSL’s (FMRIB
[The Oxford Centre for Functional Magnetic Resonance
Imaging of the Brain] Software Library) FDT toolbox
(https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT). Image ana-
lysis was performed with the software Amira (Visage
Imaging, Inc., San Diego, USA). The ischemic lesion on
ADC and T2 maps in basal ganglia and cortex was
determined by manual region growing using threshold-based
pre-segmentation.
Histopathological analysis
Animals were deeply anesthetized and transcardially
perfused with PBS (2 ml/min) for 5 min. Brains were re-
moved and embedded into Tissue-Tek (Sakura Finetek,
Staufen, Germany). From each brain, 24 coronal sections
(10 μm thickness, 0.4 mm distance) were prepared using
a Leica CM1520 cryostat (Leica Biosystems, Wetzlar,
Germany) at a constant temperature of − 15 °C, and
stained with cresyl violet (Merck Millipore, Darmstadt,
Germany, #105235) according to the manufacturer’s in-
structions. Stained brain slices were digitized, and infarct
and edema volume was measured using the image ana-
lysis software ImageJ (National Institutes of Health, Be-
thesda, MD, USA) as described previously [29, 43].
Fluoro-Jade C (FJC) staining of cerebral cryosections
(10 μm thickness; + 0.62 to − 0.62 mm relative to
Bregma) was used to detect neuronal degeneration fol-
lowing the protocol of manufacturer (Merck Millipore,
#AG325). FJC staining was recorded using a Zeiss Axio-
vert 200M microscope (Carl Zeiss Microscopy, Göttin-
gen, Germany) with a Hamamatsu ORCA flash 4.0
camera (Hamamatsu Photonics, Herrsching am Ammer-
see, Germany) by applying TissueFAXS scanning soft-
ware (TissueGnostics, Vienna, Austria). Nuclei were
identified by DAPI staining. Cells showing fluorescent
signal for FJC were automatically counted by using Tis-
sueQuest 4.0 software (TissueGnostics).
Analysis of cerebrovascular anatomy
Gross anatomical features of the cerebrovascular archi-
tecture were determined as described previously [3].
Evaluation of BBB permeability
Mice were anesthetized 2 h prior to the end of the reper-
fusion time, and 100 μl of a pre-warmed (37 °C) solution
containing 2% Evans Blue (Sigma-Aldrich, Steinheim,
Germany) in 0.9% NaCl were injected into the tail vein.
Mice were transcardially perfused, brains harvested and
separated into entire left and right hemispheres. Each
hemisphere was suspended in 500 μl ice-cold 50%
trichloroacetic acid and homogenized with a grinding
ball at 30 Hz for 2 min (Mixer Mill MM301; Retsch,
Haan, Germany). Tissue lysates were then incubated for
2 h at 4 °C and centrifuged at 16,000×g for 15 min at 4 °
C. Evans Blue in the supernatant was measured using a
spectrophotometer (Synergy HT; BioTek, Bad Friedrich-
shall, Germany) at 610 nm and quantified according to a
standard curve.
Glial cell cultures
Primary astroglial and microglial cultures were prepared
from neonatal WT, Ephb2−/− and nEfnb2Δ/Δ mice (P0-P2).
The purity of astrocyte and microglia cultures was about
96% and almost 100%, respectively (Additional file 1:
Figure S1c). Details on isolation, culture, treatment, and
analysis of microglial phagocytosis are provided in the
Supplementary Methods (Additional file 3).
Neuronal cell culture
Primary dissociated cortical cultures were prepared from
newborn WT and Ephb2−/− mice (P0). The relative por-
tion of neurons within the mixed cultures was about
83% (Additional file 1: Figure S1c). Detailed experimen-
tal procedures for isolation, culture, and treatment of
neuronal cultures as well as analysis of mitochondrial/
cytoplasmic Ca2+ concentration and mitochondrial
membrane potential can be found in the Supplementary
Methods (Additional file 3).
Immunofluorescence staining
Immunofluorescence staining techniques were applied
to determine abundance and subcellular localization of
certain proteins and were used to identify different cell
types in brain tissue sections and cellular monolayers by
detection of cell-specific marker proteins. A detailed de-
scription is given in the Supplementary Methods (Add-
itional file 3; see also Additional file 2: Table S3).
Quantitative real-time RT-PCR analysis
Mice were transcardially perfused with PBS, brains har-
vested, and a 2-mm-thick tissue slice (− 1.0 to − 3.0 mm
relative to bregma) was prepared from each brain and
separated into the left and right hemispheres. Total
RNA from brain tissue samples or cells was isolated
using the TRI reagent (Thermo Fisher Scientific,
Dreieich, Germany) according to manufacturer’s
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instructions. For digestion of residual DNA, 10 μg of
total RNA was incubated in a 25 μl reaction mix con-
taining 1x DNase-buffer, 40 U RNasin and 1 U DNase
(Promega, Mannheim, Germany) for 30 min at 37 °C.
Subsequently, cDNA was synthesized using the Access
Reverse Transcription PCR Kit (Promega, #A1260) and
quantitative real-time PCR for the target sequences was
performed in the Rotor-Gene Q (Qiagen, Hilden,
Germany) using the QuantiTect SYBR Green PCR Kit
(Qiagen). Fluorescence was monitored (excitation at 470
nm and emission at 530 nm) at the end of the annealing
phase. Threshold cycle (Ct) was set within the exponen-
tial phase of the PCR. Quantification of the PCR product
was done by using the ΔΔCt method. Amplification of
the 40S ribosomal protein S12 (Rps12) cDNA served as
an internal standard. Primers were purchased from
Eurofins Genomics (for primer sequences, see Add-
itional file 2: Table S4).
DNA microarray analysis
Mice were transcardially perfused with PBS, brains ex-
tracted, and separated into the left and right hemi-
spheres. Total RNA from brain tissue samples was
prepared using the TRI reagent (Thermo Fisher Scien-
tific) according to manufacturer’s instructions followed
by additional purification utilizing the RNeasy Mini Kit
(Qiagen). RNA was tested by capillary electrophoresis on
an Agilent 2100 bioanalyzer (Agilent, Waldbronn,
Germany) and high quality was confirmed. Gene expres-
sion profiling was performed using arrays of mouse
MoGene-2_0-st-type from Affymetrix (Santa Clara,
USA). Biotinylated antisense cRNA was then prepared
according to the Affymetrix standard labeling protocol
with the GeneChip® WT Plus Reagent Kit and the Gene-
Chip® Hybridization, Wash and Stain Kit (both from
Affymetrix). Afterwards, hybridization on the chip was
performed on a GeneChip Hybridization oven 640, then
dyed in the GeneChip Fluidics Station 450 and thereafter
scanned with a GeneChip Scanner 3000. All equipment
used was from Affymetrix (High Wycombe, UK). A Cus-
tom CDF Version 20 with ENTREZ-based gene defini-
tions was used to annotate the arrays [7]. The Raw
fluorescence intensity values were normalized by apply-
ing quantile normalization and RMA background cor-
rection. An ANOVA was performed to identify
differentially expressed genes using a commercial soft-
ware package (SAS JMP10 Genomics, version 7) from
SAS (SAS Institute, Cary, NC, USA). A false positive rate
of a = 0.05 with FDR correction was taken as the level of
significance. Gene Set Enrichment Analysis (GSEA) was
used to determine whether defined sets of genes exhib-
ited a statistically significant bias in their distribution
within a ranked gene list using the software GSEA [49].
Pathways belonging to various cell functions such as cell
cycle or apoptosis were obtained from public external
databases (KEGG, http://www.genome.jp/kegg). The raw
and normalized data are deposited in the Gene Expres-
sion Omnibus database (http://www.ncbi.nlm.nih.gov/
geo/; accession No. GSE120565).
Phospho-receptor tyrosine kinase array
Mice were transcardially perfused with PBS, brains re-
moved, and a 3-mm-thick tissue slice (+ 2.50 ± 0.5 to
0.00 ± 0.5 mm relative to bregma) was prepared from
each brain and separated into the left and right hemi-
spheres. The relative level of tyrosine phosphorylation of
39 different receptor tyrosine kinases (RTK) was deter-
mined in brain tissue samples using the Proteome Pro-
filer Mouse Phospho-RTK Array Kit (R&D Systems,
Wiesbaden, Germany, #ARY014) according to manufac-
turer’s instructions. Briefly, 500 μl lysis buffer was added
to each brain tissue slice, and tissue samples were ho-
mogenized mechanically as described above. Following
incubation on ice for 10 min, tissue homogenates were
centrifuged for 5 min at 16,100×g at 4 °C. Protein con-
centration in the supernatant was then quantified by
Bradford assay, and 250 μg protein/sample was proc-
essed further following the protocol of manufacturer.
Capillary electrophoresis
Mice were transcardially perfused with PBS, brains har-
vested, and a 2-mm-thick tissue slice (+ 3.0 to + 1.0 mm
relative to bregma) was prepared from each brain and
separated into the left and right hemispheres. Lysis buf-
fer containing 20 mM Tris (pH 7.6), 250 mM NaCl, 1
mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.5% Noni-
det P-40, 1 mM DTT, 1 mM PMSF, and 1% protease in-
hibitor cocktail (all from Sigma-Aldrich) was added to
brain tissue samples or cell monolayer. Tissue samples
were homogenized mechanically as reported above. Fol-
lowing incubation on ice for 15 min, tissue and cell ho-
mogenates were centrifuged for 15 min at 16,100×g at 4
°C. Protein concentration in the supernatant was then
quantified by Bradford assay. Analysis of protein expres-
sion was performed according to the Wes User Guide
using a Wes instrument from ProteinSimple (San Jose,
CA, USA). Briefly, protein samples were diluted with
0.1X sample buffer to a final concentration of 0.5 μg/μl,
and were mixed with fluorescent 5x Master Mix and in-
cubated at 95 °C for 5 min. The samples were loaded
into the Wes microplate along with a biotinylated pro-
tein ladder, blocking reagent, primary antibodies against
EphB2 (R&D Systems, #AF467; 1:10) and beta-tubulin
(Abcam, Cambridge, UK, #ab6046; 1:500),
HRP-conjugated anti-rabbit secondary antibody, luminol
peroxide, and washing buffer. The plates and capillary
cartridges were loaded into the Wes for electrophoresis
and chemiluminescence immunodetection using a CCD
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camera with default settings: electrophoresis, 375 V, 30
min; blocking, 5 min; primary antibody, 30 min; second-
ary antibody, 30 min; and camera exposure times, 1 s to
32 s. Compass software (ProteinSimple) was used to ac-
quire and analyze the data and to generate gel images
and chemiluminescence signal intensity values. Protein
expression is calculated as the chemiluminescence inten-
sity area under the curve.
Enzyme-linked immunosorbent assay (ELISA)
MCP-1 and TNF protein levels in cell supernatants were
measured by quantitative ELISA (R&D Systems, Mouse
MCP-1 DuoSet ELISA #DY479–05, Mouse TNF-alpha
DuoSet ELISA #DY410–05) according to manufacturer’s
instructions.
Statistical analysis
If not indicated otherwise, all results are expressed as
means and displayed on scattered dot plots ± standard
deviation (SD). Differences between 2 independent ex-
perimental groups were analyzed by two-tailed Student’s
t tests (normally distributed data) or Mann-Whitney U
rank-sum tests (ordinal and non-normal data). Differ-
ences of one parameter among three or more independ-
ent experimental groups were analyzed by either
one-way ANOVA followed by a Holm-Sidak’s multiple
comparisons test (normally distributed data), or by
Kruskal-Wallis H test with Dunn’s post hoc test (ordinal
and non-normal data). Differences of two parameters
among two or more independent/correlated experimen-
tal groups were analyzed by two-way (Repeated Mea-
sures) ANOVA followed by a Holm-Sidak’s multiple
comparisons test (normally distributed data). A probabil-
ity value of P < 0.05 was considered statistically signifi-
cant. Data plotting and statistical analyses were done
with Prism 6 (GraphPad Software, La Jolla, CA, USA).
Results
EphB2 deficiency reduces brain tissue injury and
functional disabilities after ischemic stroke
Cerebral ischemia disrupts regular receptor-ligand interac-
tions due to loss of cellular integrity. To investigate
whether the spatiotemporal distribution of the ephrin-B/
EphB family members is affected under these conditions,
we applied immunofluorescence-based analyses. The re-
sults indicate a homogenous distribution of ephrin-B1,
ephrin-B2 and EphB2 protein across the hemisphere of
coronal mouse brain sections, while EphB4 was primarily
localized in close proximity to cerebral blood vessels
(Fig. 1a). Acute focal ischemic stroke resulted in progres-
sive loss of all ephrin-B/EphB proteins exept EphB4 within
both the ipsilesional striatum and adjacent cortical tissue
representing the infarct core and ischemic penumbra, re-
spectively (Fig. 1a). Global analysis of receptor tyrosine
kinase (RTK) phosphorylation using an antibody array in
mice subjected to 60min of MCAO followed by 6 h reper-
fusion revealed significantly increased phosphorylation of
certain EphB receptor family members including EphB2
within the left ipsilesional cerebral hemisphere (Fig. 1b;
phosphorylation status of 39 different murine RTK ana-
lyzed post stroke is shown in Additional file 1: Figure S2a)
while total EphB2 protein amount did not differ between
contra- and ipsilateral brain tissue (Additional file 1:
Figure S1a).
To further analyze the role of EphB2, mice homozy-
gous for a null allele of Ephb2 (Ephb2−/−) were subjected
to I/R injury. While EphB2 was not detectable (Fig. 1a;
Additional file 1: Figure S1a), the spatial distribution of
ephrin-B1, ephrin-B2, and EphB4 in both ischemic and
non-ischemic areas of the mouse brain was not mark-
edly different from WT littermates (Fig. 1a). However,
Ephb2−/− mice showed markedly reduced neuronal cell
death across the infarct lesion during the hyperacute
phase of ischemic stroke (Fig. 1c). Global infarct lesion
volume and brain swelling due to vasogenic/cytotoxic
edema determined 12, 24 and 48 h upon onset of reper-
fusion were significantly diminished in Ephb2−/− mice as
compared to WT littermates (Fig. 1d). Decreased brain
tissue damage in Ephb2−/− mice was further associated
with reduced Bederson neurological severity scores (Fig.
1e) and improved motor dysfunction (Fig. 1f ) during the
acute stage of ischemic stroke. Interestingly, when com-
pared to WT littermates, also Ephb2 haploinsufficient
(Ephb2+/−) mice developed less severe histologic injury
and functional impairment after acute cerebral ischemia,
albeit not to the same extent as observed in Ephb2−/−
mice (Additional file 1: Figure S2b-d). Collectively, our
findings suggest that EphB2 promotes brain tissue from
damage during early acute stroke in a gene
dosage-dependent manner.
EphB2 deficiency inhibits the expression of gene sets
associated with cell death and inflammation and
promotes the expression of gene sets related to synaptic
transmission in the CNS after acute ischemic stroke
We conducted DNA microarray and subsequent gene
set enrichment analyses (GSEA) to compare the
genome-wide transcriptomic response to acute ische-
mic stroke in cerebral tissue of Ephb2−/− and WT
mice. Among others, GSEA identified four gene sets
linked to cell death that were significantly
down-regulated in the ipsilateral brain hemisphere of
Ephb2−/− compared to WT mice (Table 1, Fig. 2;
Additional file 2: Table S5). Moreover, twelve gene
sets involved in inflammation and immune cell signal-
ing were found to be significantly down-regulated in
Ephb2−/− versus WT littermates (Table 1, Fig. 2;
Additional file 2: Table S5). Six gene sets associated
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Fig. 1 (See legend on next page.)
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with synaptic function were up-regulated in the in-
farcted brain of Ephb2−/− in comparison to WT ani-
mals (Table 1, Fig. 2; Additional file 2: Table S5).
Overall, these data suggest that EphB2-dependent
signaling regulates processes determining the extent of
infarction during acute ischemic stroke such as (1)
cellular viability, (2) post-ischemic inflammation, and (3)
synaptic function.
Lack of EphB2 ameliorates brain edema following acute
ischemic stroke by diminishing the formation of cytotoxic
edema
In order to unravel cellular/molecular mechanisms
underlying the aforementioned findings in Ephb2-defi-
cient mice after acute ischemic stroke, we first investi-
gated a possible vascular mechanism, as a significant
proportion of double-mutant mice deficient in both
EphB2 and EphB3 receptor exhibit defects in the remod-
eling of the embryonic vascular system [1]. Perfusion of
the arterial system through the left ventricle of the heart
using colored particles that cannot pass the capillary sys-
tem showed a similar gross anatomy of the circle of
Willis at the base of the brain from Ephb2−/− mice ver-
sus WT littermates (Additional file 1: Figure S3a). The
average number of surface arterial branches that origin-
ate from the proximal MCA was also similar between
Ephb2−/− and WT animals (Additional file 1: Figure S3a).
Cerebral perfusion monitoring revealed that proximal
MCAO resulted in an average reduction of regional
cerebral blood flow (rCBF) by 85 ± 6% in WT and 83 ±
7% in Ephb2−/− mice (Additional file 1: Figure S3b).
Moreover, neither the density of cerebral microvessels
nor the pericyte coverage of the microvasculature was
significantly affected due to ablation of the Ephb2 gene
(Additional file 1: Figure S3c, d). These findings confirm
successful arterial occlusion in both genotypes, and ex-
clude the possibility that lack of EphB2 increases the
number or diameter of pial collaterals and/or leptomen-
ingeal arteriole–arteriole anastomoses interconnecting
distal branches of the MCA, anterior cerebral artery
(ACA), and posterior cerebral artery (PCA) trees, which
could partially compensate for disturbed blood flow after
arterial occlusion [33].
Our morphovolumetric analyses shown in Fig. 1e re-
vealed reduced brain swelling in Ephb2−/− mice suffering
from acute ischemic stroke. To address a possible role of
BBB damage, we analyzed endothelial TJ structures. Our
histological analyses disclosed a rearrangement of ZO-1
resulting in progressive gap formation at the endothelial
cell membrane of blood vessels located in the ipsile-
sional cortex and striatum, which, however, was fairly
comparable between Ephb2−/− and WT mice (Fig. 3a).
In line with the progressive structural damage of the
BBB after restoration of cerebral blood flow, the amount
of Evans blue (EB), an intravenously administered intra-
vital dye that binds to plasma albumin, extravasated into
the brain parenchyma was markedly increased in ipsile-
sional as compared to contralateral brain tissue (Fig. 3b).
The post-ischemic BBB leakage of EB upon 12 and
24 h of reperfusion was not significantly different be-
tween Ephb2−/− and WT animals (Fig. 3b), suggesting
that lack of EphB2 has no relevant direct influence on
the BBB hyperpermeability during acute ischemic
stroke. In addition to these post-mortem examina-
tions, we utilized multimodal, high-field (9.4 T) in vivo
MRI for longitudinal evaluation to assess both vaso-
genic and cytotoxic edema formation in the brain dur-
ing the acute phase of stroke using T2 relaxometry
and diffusion-weighted imaging, respectively. Apparent
diffusion coefficient (ADC) infarct volume (as deter-
mined by diffusion-weighted imaging) in the basal
ganglia of Ephb2−/− mice was significantly lower at 6 h
after reperfusion compared to WT mice while no vol-
ume differences were seen on T2 maps between both
groups, suggesting that less cytotoxic edema evolves
in Ephb2−/− mice during early time points after reper-
fusion (Fig. 3c, d). From 6 to 24 h after reperfusion
the ADC and T2 infarct volume increased in both
groups but to a significantly lesser degree in Ephb2−/−
mice (Fig. 3c, d).
(See figure on previous page.)
Fig. 1 Ephb2 null mice suffering from acute stroke show reduced brain tissue injury and functional disabilities. a WT and Ephb2−/− mice (n = 4/
group) were subjected to 60 min MCAO followed by 6 h or 24 h of reperfusion. Immunofluorescent staining was used to determine the spatial
distribution of ephrin-B1, ephrin-B2, EphB2 and EphB4 proteins in coronal brain sections. Representative immunofluorescent staining images:
ephrin-B/EphB (green) and nuclei (blue). The infarct area according to cresyl violet staining is bordered by a broken white line. Scale bar = 5 mm.
b WT mice were subjected to 60 min MCAO followed by 6 h of reperfusion. Proteins were isolated from contra-(non-ischemic) and ipsi-(ischemic)
lateral brain hemispheres and applied to proteome profiler membranes for detection of phosphorylation levels of Eph receptors (mean ± SD; n =
6; Welch’s t-test). (c) WT and Ephb2−/− mice underwent 60 min MCAO followed by 12 h of reperfusion. Brain sections were stained with Fluoro-
Jade C (FJC), and FJC-positive neurons were counted in the ipsilesional cortex (mean ± SD; n = 6; Student’s t-test). d-f WT and Ephb2−/− mice were
subjected to 60min MCAO followed by 12, 24 or 48 h of reperfusion as indicated. d Brain sections were stained with cresyl violet, and infarct and
edema sizes were analyzed using ImageJ. Infarct volume is edema-corrected (single values (scatter blots) and mean ± SD; n = 6/6, 15/15, 24/22;
Student’s t-test). e Neurological function was assessed using the Bederson neurological deficit score (single values and median; n = 8/11, 17/15,
17/11; Mann-Whitney U rank-sum test). f Motor coordination of mice subjected to 60 min MCAO followed by 24 h of reperfusion was analyzed by
using the Rotarod performance test (single values and mean ± SD; n = 5/4; Two-way ANOVA with Holm-Sidak’s multiple comparisons test). * p < 0.05
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Table 1 KEGG pathway-Based gene set enrichment analyses (GSEA)
Pathway Name NES NOM p-val FDR q-val
Nicotine addiction 2.41 < 0.001 < 0.001
Glutamatergic synapse 2.08 < 0.001 0.001
Morphine addiction 2.03 < 0.001 0.001
Retrograde endocannabinoid signaling 1.97 < 0.001 0.001
GABAergic synapse 1.87 < 0.001 0.005
Axon guidance 1.83 < 0.001 0.007
Circadian entrainment 1.78 < 0.001 0.010
Calcium signaling pathway 1.77 < 0.001 0.011
Cocaine addiction 1.73 0.004 0.015
Salivary secretion 1.56 0.002 0.070
Neuroactive ligand-receptor interaction 1.55 < 0.001 0.072
Parkinson’s disease 1.53 0.002 0.079
Dopaminergic synapse 1.51 0.005 0.082
Platelet activation − 1.50 0.003 0.048
Central carbon metabolism in cancer − 1.50 0.020 0.047
Choline metabolism in cancer −1.50 0.003 0.046
One carbon pool by folate −1.50 0.042 0.046
Hypertrophic cardiomyopathy (HCM) −1.51 0.012 0.043
TGF-beta signaling pathway −1.53 0.014 0.036
Prolactin signaling pathway −1.54 0.007 0.036
Inflammatory bowel disease (IBD) −1.55 0.018 0.031
DNA replication −1.55 0.026 0.031
NOD-like receptor signaling pathway −1.55 0.011 0.031
Colorectal cancer −1.55 0.009 0.031
Non-alcoholic fatty liver disease (NAFLD) −1.56 0.002 0.029
Cell adhesion molecules (CAMs) −1.58 0.002 0.027
Herpes simplex infection −1.60 0.002 0.022
Viral myocarditis −1.61 0.002 0.021
Melanoma −1.61 0.007 0.021
Bladder cancer −1.62 0.011 0.020
Galactose metabolism −1.63 0.011 0.019
Adipocytokine signaling pathway −1.63 0.002 0.018
Mineral absorption −1.63 0.008 0.018
Acute myeloid leukemia −1.64 0.011 0.017
Sphingolipid signaling pathway −1.65 < 0.001 0.015
MAPK signaling pathway −1.67 < 0.001 0.013
Pathways in cancer −1.67 < 0.001 0.013
Hepatitis C −1.68 < 0.001 0.012
Biosynthesis of amino acids −1.69 < 0.001 0.011
Protein digestion and absorption −1.72 < 0.001 0.008
Estrogen signaling pathway −1.72 < 0.001 0.008
Fc epsilon RI signaling pathway −1.74 < 0.001 0.007
Transcriptional misregulation in cancer −1.74 < 0.001 0.007
Natural killer cell mediated cytotoxicity −1.74 < 0.001 0.007
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Table 1 KEGG pathway-Based gene set enrichment analyses (GSEA) (Continued)
Pathway Name NES NOM p-val FDR q-val
Glioma −1.74 < 0.001 0.007
Regulation of actin cytoskeleton −1.74 < 0.001 0.007
Bacterial invasion of epithelial cells −1.75 0.002 0.007
Cell cycle −1.76 < 0.001 0.006
Chemokine signaling pathway −1.76 < 0.001 0.006
Arginine and proline metabolism −1.77 < 0.001 0.005
Measles −1.77 < 0.001 0.006
Pancreatic cancer −1.78 < 0.001 0.005
Fc gamma R-mediated phagocytosis −1.79 < 0.001 0.005
HTLV-I infection −1.79 < 0.001 0.004
FoxO signaling pathway −1.80 < 0.001 0.004
Chronic myeloid leukemia −1.82 < 0.001 0.003
Prostate cancer −1.84 < 0.001 0.003
MicroRNAs in cancer −1.84 < 0.001 0.003
Hepatitis B −1.85 < 0.001 0.002
Salmonella infection −1.85 0.002 0.002
Protein processing in endoplasmic reticulum −1.87 < 0.001 0.002
VEGF signaling pathway −1.87 < 0.001 0.002
Epstein-Barr virus infection −1.87 < 0.001 0.002
Influenza A −1.88 < 0.001 0.002
Spliceosome −1.92 < 0.001 0.001
Phagosome −1.93 < 0.001 0.001
Tuberculosis −1.93 < 0.001 0.001
Chagas disease (American trypanosomiasis) −1.94 < 0.001 0.001
Hematopoietic cell lineage −1.96 < 0.001 0.001
Toll-like receptor signaling pathway −1.97 < 0.001 0.001
Jak-STAT signaling pathway −1.97 < 0.001 0.001
PI3K-Akt signaling pathway −1.97 < 0.001 0.001
Proteasome −1.98 < 0.001 0.001
Apoptosis −2.00 < 0.001 0.001
Rheumatoid arthritis −2.00 < 0.001 0.001
Amoebiasis −2.00 < 0.001 0.001
Antigen processing and presentation −2.00 < 0.001 0.001
Pertussis −2.05 < 0.001 < 0.001
Malaria −2.06 < 0.001 < 0.001
Staphylococcus aureus infection −2.06 < 0.001 < 0.001
Legionellosis −2.06 < 0.001 < 0.001
Osteoclast differentiation −2.07 < 0.001 < 0.001
B cell receptor signaling pathway −2.07 < 0.001 < 0.001
HIF-1 signaling pathway −2.08 < 0.001 < 0.001
Leishmaniasis −2.11 < 0.001 < 0.001
Proteoglycans in cancer −2.12 < 0.001 < 0.001
p53 signaling pathway −2.13 < 0.001 < 0.001
Leukocyte transendothelial migration −2.15 < 0.001 < 0.001
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Altogether, our observations suggest that lack of EphB2
has no effect on basal or infarct-triggered loss of BBB
function but may indirectly attenuate stroke-associated
brain swelling by reducing early cytotoxic edema, which in
turn limits vasogenic edema formation.
EphB2 deficiency mitigates brain inflammation in the
acute stage following ischemic stroke
Gene set enrichment analyses on our whole genome ex-
pression data revealed a down-regulation of gene sets as-
sociated with inflammation and immune cell functions
in the infarcted cerebral tissue of Ephb2−/− mice (Table
1, Fig. 2). Given that brain tissue protection in Ephb2−/−
mice is already detectable during the first 6 h of a stroke,
we reasoned that EphB2-dependent signaling might be
involved in immediate early post-ischemic
pro-inflammatory processes. Immunofluorescence tech-
niques revealed an increasing number of neutrophils
infiltrating the ipsilateral hemisphere from 6 to 24 h
upon onset of reperfusion, whereas the frequency of
neutrophils located at the non-affected brain hemisphere
remained unchanged as compared to sham-operated
animals (Fig. 4a; Additional file 1: Figure S4). The early
post-ischemic recruitment of neutrophils into the brain
of Ephb2−/− mice was not significantly different from
WT mice (Fig. 4a). In response to an ischemic insult,
resident microglia and astrocytes localized in close vicin-
ity to the infarct lesion site undergo cellular activation
that causes morphological and immunophenotypic
changes, enhanced proliferation, and increased produc-
tion and release of cytokines, chemokines, and ROS
[22]. Accordingly, as compared to sham-operated con-
trol animals, the number of both microglia/macrophages
(Fig. 4b; Additional file 1: Figure S4) and astrocytes
(Fig. 4c; Additional file 1: Figure S4) within the
peri-infarct region gradually increased from 24 to 72 h
post-reperfusion, but the quantities of microglia/macro-
phages and astrocytes across the peri-infarct zone of
Ephb2−/− mice were quite similar to those in WT
littermates (Fig. 4b, c). Unfortunately, Iba1 did not allow
distinguishing activated from resting microglia. At 12 h
post-reperfusion, prior to any substantial accumulation of
activated glial cells along the infarct border zone, we
determined a markedly increased expression of key
pro-inflammatory factors such as Mcp-1, Il-1beta, Il-6,
and Cox-2, which was significantly less pronounced in the
ipsilesional brain tissue of Ephb2−/− mice in comparison
to WTanimals (Fig. 4d).
EphB2/ephrin-B reverse signaling promotes pro-
inflammatory activation of astrocytes through activation
of NF-κB
The above-mentioned results prompted us to study the
role of EphB2/ephrin-B signaling in the inflammatory
activation of microglia and astrocytes. Primary murine
microglia, which were isolated from cortices of WT mice
and exposed to either oxygen-glucose deprivation
(OGD) or basal conditions in vitro, responded to stimu-
lation with pre-clustered recombinant EphB2/Fc fusion
proteins with a transcriptional up-regulation of Tnf,
whereas the expression of Mcp-1 and Il-1beta remained
unchanged (Fig. 5a). On the contrary, the treatment with
pre-clustered ephrin-B1 and ephrin-B2, two ligands of
EphB2, did not affect inflammatory factor expression of
non-stressed microglia (Additional file 1: Figure S5a). In
microglia faced with OGD stress, ephrin-B2 increased
the expression of Il-1beta (Additional file 1: Figure S5a).
The phagocytic activity of both OGD- and non-stressed
microglia was not altered by either EphB2, ephrin-B1 or
ephrin-B2 (Additional file 1: Figure S5b). To further
clarify the impact of EphB2/ephrin-B forward signaling
on microglial activation, microglia isolated from the cor-
tices of Ephb2−/− mice were treated with ephrin-B1 or
ephrin-B2. Neither the phagocytic activity nor the ex-
pression of pro-inflammatory factors of Ephb2−/− micro-
glial cells exposed to ischemic or control conditions
Table 1 KEGG pathway-Based gene set enrichment analyses (GSEA) (Continued)
Pathway Name NES NOM p-val FDR q-val
Complement and coagulation cascades −2.16 < 0.001 < 0.001
TNF signaling pathway −2.17 < 0.001 < 0.001
NF-kappa B signaling pathway −2.20 < 0.001 < 0.001
Toxoplasmosis −2.22 < 0.001 < 0.001
Cytokine-cytokine receptor interaction −2.23 < 0.001 < 0.001
Small cell lung cancer −2.27 < 0.001 < 0.001
Focal adhesion −2.29 < 0.001 < 0.001
ECM-receptor interaction −2.46 < 0.001 < 0.001
Ephb2−/− and WT mice (n = 3) were subjected to 60min MCAO followed by 48 h reperfusion. Total RNA was extracted from ipsilesional brain tissue and processed
for DNA microarray analysis (GeneChip Mouse Gene 2.0 ST; Affymetrix, Santa Clara, CA, USA). The table lists all significantly UP and DOWN-regulated gene sets
comparing Ephb2−/− versus WT matching the following criteria for selection: ≥1.5- or ≤ 1.5-fold regulation (log2-fold), p < 0.05 (ANOVA), FDR < 0.1. NES: normalized
enrichment score; FDR: false discovery rate
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Fig. 2 EphB2 deficiency alters gene expression related to cell death, inflammation and synaptic transmission after stroke. WT and Ephb2−/− mice
(n = 3/group) were subjected to 60min MCAO followed by 48 h of reperfusion. Total RNA was isolated from the ipsilateral brain hemisphere and
processed for genome array analysis. Exemplary results (enrichment plots) for selected gene sets associated with (a, c) synaptic transmission, (b)
cell death and (d) inflammation, the corresponding statistical values and excerpt of the corresponding heat maps are shown. NES, normalized
enrichment score; p, P-value (ANOVA); FDR: false discovery rate
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were markedly affected upon treatment with ephrin-B1
or ephrin-B2 (Additional file 1: Figure S5a, b). Overall,
our results do not point to an important role of EphB2/
ephrin-B forward or reverse signaling for the activation
of resident microglia during early acute ischemic stroke.
Primary murine astrocytes isolated from brain tissue
of WT mice showed significantly increased mRNA levels
of Mcp-1, Tnf and Il-1beta upon treatment with EphB2
(reverse signaling, Fig. 5b). A pro-inflammatory response
to EphB2, albeit to a lesser extent, was also observed in
astrocytes subjected to OGD (Fig. 5b). Astrocytic
up-regulation of MCP-1 and TNF upon EphB2
treatment was further confirmed at the protein level
(Fig. 5b). By contrast, ephrin-B1- or ephrin-B2-induced
forward signaling did not elevate inflammatory factor
expression of either OGD- or non-stressed astrocytes
(Additional file 1: Figure S5c). In Ephb2−/− astrocytes
(Additional file 1: Figure S6a) cultured under basal
conditions, ephrin-B2, but not ephrin-B1, reduced the
expression of Mcp-1, Tnf, and Il-1beta. However, the
anti-inflammatory transcriptional response towards
ephrin-B2 was not detectable in Ephb2−/− astrocytes
Fig. 3 Lack of EphB2 ameliorates brain edema following acute stroke by diminishing formation of cytotoxic edema. a WT and Ephb2−/− mice
underwent 60min MCAO followed by 6 or 24 h of reperfusion. Brain sections were subjected to immunofluorescent staining of CD31 and ZO-1 to
visualize interendothelial tight junctions. For each mouse disruptions (gaps; denoted by white arrowhead) of the regular ZO-1 localization pattern were
counted in 10–30 randomly chosen microvessels localized within the ipsilesional striatum (infarct core) and cortex (periinfarct), respectively (mean ±
SD; n = 4/4, n = 4/4; Two-way ANOVA with Holm-Sidak’s multiple comparisons test). Scale bar = 10 μm. b WT and Ephb2−/− mice were subjected to 60
min MCAO followed by 12 or 24 h of reperfusion. Evans Blue was applied by tail vein injection 2 h before end of the experiment. After transcardial
perfusion the amount of Evans Blue was quantified within contra- and ipsilateral brain hemisphere using absorption spectroscopy (mean ± SD; n = 3/4,
n = 9/8; Two-way ANOVA with Holm-Sidak’s multiple comparisons test). c, d WT and Ephb2−/− mice were subjected to 60min MCAO followed by 24 h
of reperfusion. High-field (9.4 T) in vivo MRI was applied to monitor spatiotemporal development of vasogenic (T2-weighted imaging) and cytotoxic
(ADC maps derived from diffusion-weighted imaging) edema post-stroke. Representative brain T2- and diffusion-weighted images of WT and Ephb2−/−
mice in coronal planes are depicted in (c). d shows quantification of the ischemic lesion volume on T2 and ADC maps in basal ganglia (single values
and mean ± SD; n = 9/8; Two-way ANOVA with Holm-Sidak’s multiple comparisons test). * p < 0.05
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subjected to OGD (Additional file 1: Figure S5c). Next,
we investigated whether EphB2-induced reverse signal-
ing is mediated via the activation of astrocytic
ephrin-B1, ephrin-B2 or both. EphB2 treatment of
non-stressed cortical astrocytes isolated from transgenic
mice having a deficiency for the Efnb2 gene in cells of the
neural lineage (Additional file 1: Figure S6b) failed to
up-regulate Tnf and Il-1beta, while transcription of Mcp-1
was still significantly increased, albeit to a lesser extent as
compared to WT astrocytes (Fig. 5b). Exposure to OGD
stress enhanced the responsiveness of Efnb2−/− astrocytes
for EphB2 and resulted in significant up-regulation of
Mcp-1 and Tnf (Fig. 5b). Thus, our findings suggest that
EphB2-induced reverse signaling through both ephrin-B1
and ephrin-B2 drives the pro-inflammatory activation of as-
trocytes. In an attempt to unravel the molecular basis
underlying the EphB2-mediated inflammatory activation of
astrocytes, we demonstrated that EphB2 favors the nuclear
translocation of NF-κB, well known to promote the expres-
sion of pro-inflammatory factors at the transcriptional level
(Fig. 6a). Accordingly, pre-treatment with BAY 11–7082, a
potent inhibitor of the IκB kinase (key upstream regulator
of NF-κB), completely prevented the EphB2-induced
up-regulation of Mcp-1, Tnf, and Il-1beta (Fig. 6b). More-
over, pharmacological inhibition of mitogen-activated
protein kinase kinase 1 and 2 (MAP2K1/2), which phos-
phorylates extracellular-signal-regulated kinase 1 and 2
(ERK1/2) and p38 MAPK, prior to EphB2 stimulation
prevented transcriptional up-regulation of Mcp-1 (Fig. 6c)
and Il-1beta (Fig. 6d), respectively. In contrast, inhibition of
Src-family kinases (Additional file 1: Figure S7a), c-Jun
N-terminal kinase (JNK; Additional file 1: Figure S7b) or
phosphoinositide 3-kinase (PI3K; Additional file 1: Figure
S7c), which have also been described as downstream targets
of phosphorylated ephrin-B1 or -B2 and activators of
NF-κB, did not impede EphB2-induced up-regulation of
Fig. 4 EphB2 deficiency mitigates brain inflammation in the acute stage after ischemic stroke. a-c WT and Ephb2−/− mice underwent 60 min
MCAO followed by either 6, 12, 24, 48 or 72 h of reperfusion or were subjected to sham surgery. Immunofluorescent staining of Ly6G, Iba-1 and
GFAP was applied to determine the number of (a) infiltrating neutrophils within the contra- and ipsilateral brain hemisphere (mean ± SD; n = 4/4;
Two-way ANOVA with Holm-Sidak’s multiple comparisons test), (b) microglia/macrophages and (c) astrocytes along the infarct border zone
(mean ± SD; n = 4/4; Two-way ANOVA with Holm-Sidak’s multiple comparisons test). d RNA was extracted from ipsilesional brain tissue and
corresponding tissue of sham operated mice. Expression of pro-inflammatory factors in brain tissue 12 h upon restoration of MCA perfusion was
evaluated by quantitative real-time RT-PCR (mean ± SD; n = 3/3; Two-way ANOVA with Holm-Sidak’s multiple comparisons test). S, sham; M,
MCAO. * p < 0.05
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either Mcp-1, Tnf, or Il-1beta (Additional file 1: Figure
S7a-c). We further analyzed whether ischemic stress condi-
tions affect the expression of ephrin-B1 and ephrin-B2 in
glial cells, and thus might alter their responsiveness toward
EphB2. Indeed, exposure of microglia and astrocytes to is-
chemic or pure hypoxic conditions significantly increased
the mRNA expression of Efnb2, while the transcript levels
of Efnb1 and Ephb2 remained unchanged as compared to
control conditions (Additional file 1: Figure S8a). Given that
reduction of the cellular oxygen level was sufficient to
up-regulate glial ephrin-B2, we investigated the possibility
that Efnb2 is transcriptionally regulated through
hypoxia-inducible factor (HIF). Cells were treated with
dimethyloxallyl glycine (DMOG), an inhibitor of the prolyl
4-hydroxylase domain proteins (PHD), which act as key
suppressors of the HIF pathway. While astrocytes
responded to DMOG with a strong up-regulation of the
classical HIF target gene Vegfa, the mRNA levels of Efnb2
remained stable over time (Additional file 1: Figure S8b).
The latter suggests that the PHD-HIF axis is not respon-
sible for the oxygen-dependent Efnb2 gene expression.
However, in ipsilesional brain tissue of mice subjected to I/
R injury, neither Efnb2 nor Efnb1 or Ephb2 were found to
be differently expressed compared to levels measured in
cerebral tissue from sham-treated animals (Additional file
1: Figure S8c).
Collectively, our results indicate that EphB2-mediated
activation of both ephrin-B1 and ephrin-B2 promotes
the NF-κB-dependent pro-inflammatory activation of as-
trocytes, but not microglia, through activation of MAPK
signaling.
EphB2 deficiency prevents NMDAR-evoked excitotoxic
mitochondrial depolarization in neurons
Excessive release of glutamate into the extracellular
space and subsequent overactivation of NMDARs is a
crucial step in the ischemic cascade [10]. Given the re-
duced neuronal cell death and extent of acute cytotoxic
edema in Ephb2-deficient mice (Figs. 1c, 3c, d) upon is-
chemic stroke, we hypothesized that in this context
EphB2 activation (Fig. 1b) contributes to neuronal
excitotoxicity. In light of the importance of
NMDAR-mediated excitotoxicity during cerebral ische-
mia [28], we consequently aimed at analyzing the func-
tion of NMDARs in EphB2-deficient neurons in the
context of excitotoxicity.
To this end, primary cortical cultures, consisting of >
80% neurons, were isolated from brains of newborn (P0)
WT and Ephb2−/− mice, and cultured for ten days in
vitro (DIV10) to achieve the development of an exten-
sive network of synaptic contacts [53], and proper sus-
ceptibility to NMDA-induced excitotoxicity [12]. Along
with this, we confirmed that DIV10 neurons express
EphB2 protein on the cell surface (Additional file 1:
Figure S9). Cytoplasmic and mitochondrial Ca2+ levels,
as well as changes in mitochondrial membrane potential,
were evaluated before and during NMDAR stimulation.
In order to prevent action potentials (APs) and
Fig. 5 EphB2/ephrin-B reverse signaling promotes pro-inflammatory
activation of astrocytes. a Primary microglia isolated from brains of
neonatal WT mice were exposed to normoxic or OGD conditions for
6 h in the presence of either 10 nmol pre-clustered EphB2/Fc or anti-
IgG Fc. Gene expression was determined by quantitative real-time
RT-PCR (mean ± SD; n = 5 (N), n = 4 (OGD); Student’s t-test). b
Primary astrocytes derived from brains of new born WT and
nEfnb2Δ/Δ mice were exposed to normoxic or OGD conditions for 6
h in the presence of either pre-clustered EphB2/Fc or anti-IgG Fc.
Gene expression was determined by quantitative real-time RT-PCR
(mean ± SD; n = 6/4 (N), n = 3/4 (OGD); Student’s t-test) and ELISA
(mean ± SD; n = 12/9 (N); Student’s t-test). * p < 0.05
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Fig. 6 (See legend on next page.)
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associated Ca2+ signals not mediated through NMDAR
activation, neurons were treated with drugs, which in-
hibit voltage-dependent Ca2+ channels, AMPA receptors
(AMPARs), and voltage-dependent sodium channels.
Those treatments already caused a decrease of baseline
mitochondrial Ca2+ levels, assessed as a decrease in the
baseline 4mt.D3cpv FRET ratio, in Ephb2−/− neurons.
Further, the NMDA-triggered increase in mitochondrial
Ca2+ levels was significantly reduced in Ephb2−/− neu-
rons when compared to WT neurons (Fig. 7a, b). This
suggests that mitochondrial Ca2+ homeostasis regulated
by NMDARs is impaired already under baseline condi-
tions when EphB2 is absent and that neurons are pro-
tected from excitotoxic mitochondrial Ca2+ overload by
the lack of EphB2.
As extrasynaptic NMDAR stimulation is known to
promote cell death via breakdown of the mitochondrial
membrane potential, the next experiments aimed at
identifying whether and how the absence of EphB2 may
influence mitochondrial membrane potential responses
to NMDAR stimulation. Cells were loaded with the
fluorescent dye Rhodamine 123 (Rh123). Exposing neu-
rons to the mitochondrial uncoupler FCCP results in
maximum fluorescence intensity of Rh123. Neurons
were stimulated with NMDA and changes in Rh123
fluorescence intensity, expressed as % of the
FCCP-evoked maximum, were quantified. Stimulation
with low-dose NMDA did not lead to changes in Rh123
fluorescence and did not reveal any differences between
the two genotypes. However, when cells were treated
with high-dose NMDA, Ephb2−/− neurons showed a sig-
nificantly smaller increase in Rh123 intensity when com-
pared to WT neurons indicating that Ephb2−/− neurons
are less susceptible to the NMDA-induced mitochon-
drial membrane depolarization that is associated with
mitochondrial Ca2+ overload during an excitotoxic
stimulus (Fig. 7c, d).
Ca2+ imaging using the ratiometric dye fura-2 was per-
formed to examine global cytoplasmic Ca2+ levels at
baseline and during selective stimulation of NMDARs as
above. Neither baseline nor NMDA-stimulated cytoplas-
mic Ca2+ rises were different between the two genotypes.
These results indicate that NMDAR-mediated cytoplas-
mic Ca2+ signaling is not affected upon loss of EphB2
(Fig. 7e).
Synaptic activity can trigger a nuclear Ca2+-driven
neuroprotective gene program leading to a reduction in
excitotoxicity-associated mitochondrial Ca2+ load [9, 59].
Consequently, neurons are less sensitive to excitotoxic
cell death and ischemia [9, 51, 58]. AP bursting was trig-
gered by treatment with the type A
gamma-aminobutyric acid receptor (GABAaR) antagon-
ist gabazine, and cytoplasmic and mitochondrial Ca2+ re-
sponses were measured with Fura-2 and 4mt.D3cpv,
respectively. The amplitudes of cytoplasmic Ca2+ re-
sponses to a single burst of APs were attenuated in
Ephb2−/− neurons (Additional file 1: Figure S10a). How-
ever, mitochondrial Ca2+ rises in response to an AP
burst were not different between genotypes (Additional
file 1: Figure S10b, c).
Taken together, our imaging data show both attenuated
NMDAR-dependent mitochondrial Ca2+ signaling and di-
minished sensitivity of the mitochondrial membrane poten-
tial to NMDAR stimulation in Ephb2−/− neurons. These
findings support the hypothesis that EphB2 deficiency pro-
tects neurons from NMDAR-induced excitotoxicity.
Ephrin-B2 deficiency reduces brain tissue injury in mice
suffering from acute ischemic stroke
The early phosphorylation of EphB2 (Fig. 1b) after the on-
set of ischemia, prompted us finally to have a closer look
at its ligand ephrin-B2. Thus, we analyzed whether condi-
tional ablation of the Efnb2 gene in cells of the neural
lineage may result in a similar protection of the murine
CNS from acute ischemic stroke as indicated for Ephb2−/−
mice (Fig. 1c-f). In fact, nEfnb2Δ/Δ mice showed a signifi-
cantly decreased infarct lesion size and brain swelling in
comparison to Efnb2fl/fl littermates (Fig. 8).
Overall, our experimental data strongly suggest that
glutamate-induced excitotoxic neuronal damage and in-
flammation during early acute ischemic stroke is sub-
stantially enhanced by EphB2/ephrin-B2 forward and
reverse signaling in neurons and astrocytes, respectively.
Discussion
Several previous studies in rodent models of cerebral is-
chemia have demonstrated that EphB/ephrin-B signaling
is important for the regulation of delayed endogenous
adaptive processes such as neurogenesis [11, 55] and
angiogenesis [14, 56], and as such promotes long-term
(See figure on previous page.)
Fig. 6 EphB2 promotes NF-κB-dependent pro-inflammatory activation of astrocytes through activation of Erk and p38-MAPK signaling cascade. a
Astrocytes isolated from brains of neonatal WT mice were treated with 10 nmol pre-clustered EphB2/Fc, anti-IgG Fc or 30 nmol rmTNF for 6 h.
Immunofluorescent staining was used to determine the nuclear accumulation of NF-κB (mean ± SD; n = 3; Student’s t-test). The top-right panel
shows representative immunofluorescent staining images: NF-κB (red) and nuclei (blue). b-d Astrocytes were treated with either (b) 10 μM Bay
11–7082, (c) 20 μM PD98059 or (d) 10 μM SB203580 for 1 h prior to stimulation with pre-clustered EphB2/Fc or anti-IgG Fc for 6 h. Gene
expression was analyzed by quantitative real-time RT-PCR (mean ± SD; n = 3 (Bay 11–7082), n = 3 (PD98059), n = 4 (SB203580); One-way ANOVA
with Holm-Sidak’s multiple comparisons test). * p < 0.05
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recovery from ischemic stroke. Whether or not EphB/
ephrin-B family members are also involved in acute
events during the pathogenesis of stroke is, however, en-
tirely unknown. To the best of our knowledge, we here
provide the first experimental evidence that
EphB2-dependent signaling is crucial for certain patho-
physiological processes that are initiated in the early
acute phase after ischemic stroke. The major novel find-
ings of the present study include the following: (1) loss
of EphB2 function diminishes infarct size, brain swelling
and functional impairments in the early acute stage of
ischemic stroke. (2) Acute inflammatory gene expression
in response to cerebral ischemia is reduced in Ephb2-de-
ficient mice. On the cellular level, EphB2/ephrin-B re-
verse signaling drives NF-κB- and MAPK-dependent
pro-inflammatory activation of resident astrocytes. (3)
The extent of cytotoxic edema developing in the infarct
core within the first few hours after stroke onset was
strongly decreased in Ephb2-deficient brains. Accord-
ingly, neurons lacking EphB2 show a reduced vulnerabil-
ity to mitochondrial dysfunction in the course of
NMDA-induced excitotoxicity.
On the mechanistic level, the observed decrease in in-
farct size in Ephb2-deficient mice may originate from an
alteration of multiple cellular and molecular interactions
as EphB/ephrin signaling may influence the function of
different cell types belonging to the vascular, immune or
neuronal system. In fact, with respect to the vascular
unit, a putative impact of EphB2 on the cerebrovascular
anatomy and functionality is deduced from studies sug-
gesting that mesenchymal EphB2 is required to commu-
nicate with vascular endothelial ephrin-B-ligands for
adequate blood vessel development [1]. Moreover,
ephrin-B2/EphB4 signaling has been shown to be in-
volved in the restoration of the BBB and neurovascular
repair mechanisms upon cerebral ischemia [14], under-
lining the importance of ephrin/Eph communication at
the neurovascular interface for cellular responses to
stroke. However, our study revealed that neither cere-
brovascular anatomy, capillary density, and pericyte
coverage, nor the reduction in rCBF upon MCAO was
altered in Ephb2-deficient as compared to WT mice sug-
gesting that loss of EphB2 does not directly affect the
phenotype of vascular cells in response to cerebral ische-
mia. Additionally, we investigated the functional re-
sponses of the vascular unit and analyzed the
development of vasogenic edema that evolves from an
increase in permeability of the BBB thereby allowing ex-
travasation of fluid into the brain parenchyma [13].
However, as assessed by immunofluorescence-, dye ex-
travasation-, and MRI-based analyses, vascular gap for-
mation, BBB hyperpermeability, and vasogenic edema
formation were comparable in mutant and WT mice
within the first 6 h upon cerebral ischemia. Collectively,
(See figure on previous page.)
Fig. 7 EphB2 deficiency inhibits NMDAR-dependent mitochondrial Ca2+ responses and mitochondrial membrane depolarization in neurons. WT
and Ephb2−/− forebrain neurons were obtained from P0 mice. a, b Mitochondrial calcium imaging using the FRET-based indicator 4mt.D3cpv was
performed with drugs in the bath to inhibit voltage-dependent calcium channels, AMPA receptors, and voltage-dependent sodium channels. This
should prevent APs and associated voltage-dependent calcium signals, leaving the “pure” NMDA signal, which was evoked by a brief (30 s)
application of 20 μM NMDA. a Representative data from one coverslip each of WT and Ephb2−/− cells showing the baseline 4mt.D3cpv FRET ratio
in the presence of inhibitors and the response to NMDA (mean ± SEM). b Quantification of the baseline 4mt.D3cpv FRET ratio and peak
amplitude of the response to NMDA (mean ± SD; n = 15/19 coverslips from 4 independent preparations; Student’s t-test). c, d Mitochondrial
membrane potential imaging using the fluorescent dye Rh123. Under basal conditions, Rh123 accumulates within the mitochondrial matrix,
where its high concentration leads to quenching. Mitochondrial membrane depolarization induces leakage of Rh123 from the mitochondria into
the cytoplasm, where its fluorescence is dequenched resulting in an increase in fluorescence intensity. Rh123 fluorescence levels were measured
in the nucleus to avoid possible contamination by fluorescence signals emerging from mitochondria. c Representative data from one coverslip
each of WT and Ephb2−/− cells during stimulation with 20 μM NMDA over ~ 10 min (mean ± SEM). d Quantification of the area under the curve
during the first 9 min of NMDA treatment for 5 and 20 μM NMDA (mean ± SD; n = 10 coverslips from 4 independent preparations (5 μM), n = 16/
21 coverslips from 4 independent preparations (20 μM); Student’s t-test). e Quantification of cytoplasmic Ca2+ levels under baseline conditions
and the peak amplitude of the cytoplasmic Ca2+ response as measured using the ratiometric small molecule indicator fura-2 triggered by brief
(30 s) stimulation with 20 μM NMDA (mean ± SD; n = 15/16 coverslips from 4 independent preparations; Student’s t-test). * p < 0.05
Fig. 8 Ephrin-B2 deficiency reduces brain tissue injury in mice
suffering from acute ischemic stroke. Efnb2fl/fl and nEfnb2Δ/Δ mice
were subjected to 60 min MCAO followed by 24 h of reperfusion.
Brain sections were stained with cresyl violet, and infarct and edema
sizes were analyzed using ImageJ. Infarct volume is edema-corrected
(single values and mean ± SD; n = 6/5; Student’s t-test). * p < 0.05
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none of our findings supports a primary role of vascular
EphB2 on infarct and edema formation.
Another aspect of the EphB/ephrin-B system is its
capacity to modulate immune responses, a feature which
may provide an alternative explanation for the observed
less severe stroke response of Ephb2-deficient mice. In
fact, EphB6 deficient mice show an impaired T-cell func-
tion [35, 36], and ephrin-B1 and ephrin-B2 are required
to retard the internalization of IL-7Rα from the T-cell
surface [34]. Furthermore, monocytes express several
types of EphB receptors [5, 26, 41] and upregulate
EphB2 expression upon activation [5, 45] to allow for
binding of compatible ephrin-B ligands promoting the
release of MCP-1 and IL-8 [5]. Here, we show that the
early (12 h) expression of prototypic mediators of I/R-as-
sociated pro-inflammatory responses such as MCP-1 or
IL-6 was decreased in Ephb2-deficient mice while the in-
filtration of microglia/macrophages and astrocytes into
the peri-infarct region was not altered. Mechanistically,
especially the pro-inflammatory activation of astrocytes
may be supported under these conditions by triggering
an EphB2/ephrin-B reverse signaling to stimulate
NF-κB-mediated cytokine expression via the MAPK
pathway as evidenced by our in vitro findings. Interest-
ingly, a recent report indicates that astrocytic ephrin-B1
reverse signaling induced by its interaction with the
neuronal EphB receptor is responsible for synapse en-
gulfment [25]. Along these lines, it is tempting to specu-
late that loss of synaptic EphB2 may also affect
ephrin-B1-dependent astrocyte activation after cerebral
injury. However, whether the attenuated inflammatory
response we observed is a direct consequence of an en-
vironment devoid of EphB2 receptors or is indirectly
caused by the reduced number of neurons dying due to
excitotoxicity cannot be fully elucidated based on the
chosen experimental setup.
Cytotoxic brain edema triggered by neuronal swelling
is the main cause of mortality following cerebral ische-
mia [44]. Neuronal swelling owing to ischemic stress is
rapidly initiated by aberrant depolarization and entry of
sodium and chloride ions, primarily caused by reduced
activity of the Na+/K+ ATPase and accumulation of
extracellular glutamate due to synaptic release/spillover,
impairment or reversal of uptake mechanisms, and acti-
vation of voltage-dependent channels. The resultant in-
crease of cytoplasmic sodium and chloride causes an
osmotic imbalance that leads to water entry and cyto-
toxic edema contributing to neuronal cell death within
minutes to hours upon cerebral ischemia [44]. Our MRI
studies revealed a reduced cytotoxic edema in the infarct
core of Ephb2-deficient mice already 6 h after cerebral
ischemia, and thus point to a potential relationship be-
tween neuronal EphB2 function and the extent of glu-
tamate excitotoxicity during ischemic stroke. NMDARs,
glutamate and voltage-gated ion channels permeable for
calcium, are central for the pathological processes that
underlie glutamate excitotoxicity [28]. In addition to
their synaptic localization, NMDARs are found at extra-
synaptic sites. The subunit composition of the receptors
within and outside synaptic contacts is similar, although,
in addition to carrying the common GluN1 subunit,
extrasynaptic NMDARs contain preferentially the
GluN2B subunit, whereas GluN2A is the predominant
subunit in synaptic NMDARs [2]. Paradoxically, activa-
tion of synaptic NMDARs induces neuroprotective
mechanisms, whereas stimulation of extrasynaptic
NMDARs promotes neuronal cell death. This difference
results from the activation of distinct genomic programs
and from opposing actions on intracellular signaling
pathways [2, 19, 20]. Thus, any shift in balance to reduce
synaptic or enhance extrasynaptic NMDAR signaling
may be detrimental to neuronal viability [39]. Calcium
overload-induced mitochondrial dysfunction is a central
component in the glutamate-evoked excitotoxic injury of
CNS neurons [47]. It is noteworthy to mention that
extrasynaptic NMDARs may be in close contact with
mitochondria, whereas the postsynaptic scaffold, and
also the spine structure as such, keeps mitochondria at a
distance to synaptic NMDARs [2]. Thus, upon stimula-
tion of extrasynaptic, but not synaptic NMDA receptors,
mitochondria are exposed to high and possibly damaging
calcium rises [2]. Interestingly, several previous studies
clearly demonstrated that EphB2 controls the assembly,
localization and activity of NMDARs in neurons. On a
mechanistic level, the ephrin-B-induced phosphorylation
of a single tyrosine (Y504) in the extracellular domain of
EphB2 leads to direct recruitment of NR1 and its associ-
ated subunits NR2A and NR2B to EphB2 [8, 16, 17].
Along with binding and clustering of NMDARs,
ephrin-B2-mediated activation of EphB2 also enhances
glutamate-stimulated Ca2+ influx through the NMDAR
[50]. The latter requires the cytoplasmic tyrosine kinase
domain of EphB2 recruiting and activating Src family
members, which in turn phosphorylate NR2B at Y1472,
which itself is of crucial importance for the synaptic
localization and retention of NMDARs [38, 50]. Thus, it
is tempting to speculate that neuronal EphB2 may be a
positive regulator of extrasynaptic NMDARs. In fact, our
own work revealed that loss of EphB2 in post-natal neu-
rons selectively diminished mitochondrial Ca2+ load
upon activation of NMDAR but not in response to AP
bursting. On the molecular level, excessive Ca2+ influx
into mitochondria decreases the electrochemical gradi-
ent across the mitochondrial membrane leading to re-
duced ATP synthesis, release of pro-apoptotic proteins,
activation of calcium-dependent proteases and elevated
ROS production [42]. Consistent with the inhibition of
mitochondrial Ca2+ overload, which triggers
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mitochondrial dysfunction during glutamate excitotoxi-
city, mitochondrial membrane depolarization was less
distinct in Ephb2-deficient neurons in comparison to
WT neurons stimulated with NMDA. Along this line,
we showed for the first time that EphB2 is rapidly acti-
vated in the CNS of mice suffering from cerebral ische-
mia. Moreover, brain-specific loss of ephrin-B2 in mice
reduced the extent of cerebral tissue damage in the
acute phase of ischemic stroke.
Conclusion
Taken together, our experimental data indicate that
EphB2 signaling (i) contributes to the excitotoxic
NMDAR-dependent Ca2+ overload of mitochondria and
subsequent mitochondrial membrane depolarization and
cell death in neurons, and (ii) promotes the
pro-inflammatory activation of astrocytes. These findings
indicate an important role of the EphB/ephrin-B system
during acute ischemic stroke. Further, our results sug-
gest that inhibition of EphB2 may specifically attenuate
extrasynaptic NMDAR function, and thereby improve
stroke outcome.
Although NMDAR-mediated excitotoxicity is a central
feature of neuronal cell death in stroke as well as in
other neurodegenerative diseases, NMDARs are also im-
portant for cell survival and plasticity [39]. Recent data
suggest that this dual role for neuronal survival and
death depends on the subcellular localization and sub-
unit composition of NMDARs [2, 54]. Although all clin-
ical trials aimed at blockade of NMDAR function to
treat stroke patients failed, new hope comes from studies
focusing on death-signaling pathways downstream from
extrasynaptic NMDARs [54]. As a new therapeutic ap-
proach, we here suggest to specifically attenuate detri-
mental extrasynaptic NMDAR activity by inhibition of
the EphB/ephrin-B system. This approach might shift
the balance towards pro-survival signals mediated
through synaptic NMDAR-induced processes [2].
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